Jupiter Neurosciences, Inc.
corporate_fare Company Profile
Jupiter Neurosciences, Inc. (NASDAQ:JUNS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 40 items for JUNS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-28, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for JUNS spans 8-K, 424B5, 10-Q, 424B3.
Recent high-impact activity:
- Nasdaq Moves to Delist Jupiter Neurosciences After $35M Market Value Miss
- Nasdaq Moves to Delist Jupiter Neurosciences; Company to Appeal
- Jupiter Neurosciences Raises $2M at $6.50/Share, Aims to Regain Nasdaq Compliance
- Jupiter Neurosciences Prices $2M Offering and Draws $851K More from Yorkville SEPA
- Jupiter Neurosciences Prices $2M Registered Direct Offering at $6.50/Share
Financial Snapshot
Dilution Risk
Moderate riskFiling-implied dilution signals for JUNS, detected from its recent SEC filings · based on capital-structure filings through 2026-08-24.
Registered Direct Offering Priced · Dilution Impact
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →